Novela Neurotech

Platform that cuts clinical development time of neurostimulation...


(

Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9

Novela Neurotech:
Fast Facts

  • San Francisco Bay Area based medtech startup.
  • Smart medtech platform, significantly reduces the development time and cost of neurological treatments.
  • 10 years of University R&D – Waterloo Canada.
  • US Operation Start Date: October 2018
  • Applications include epilepsy, narcotic addiction, Parkinson’s disease, and many more.

Medicinal Matters

New Frontiers in Neurotechnology

There is a new technology paradigm to better understand, treat and augment our brains.

Novela Neurotech recognizes this shift in medicinal matters and has developed a smart medtech platform that is set to revolutionize the development of neurological treatments.

The “(N)eureka” Moment

How It Works

  • Scalable. Enables large multi-site collaborative clinical experiments.
  • Intuitive. Acquire, analyze and share data with no programming or extensive training.
  • Smart. Automated neurostimulation protocols based on data collected.
  • Precise. The Use of closed-loop methods enables precise diagnostics and more effective treatments.
  • Broad application platform. Including epilepsy, narcotic addiction and Parkinson’s disease and many more.

The Neureka™ Platform Workflow

Platform Overview

Neureka™ is composed of several modules, working in concert:



What We’ve
Accomplished

The Brains Behind Novela Neurotech

RAY ISKANDER
CEO, COMPANY VISIONARY
Former Fortune 500 top executive. Passionate IoT & AI technologist, investor and entrepreneur. Strong track record in university spinoffs, licensing, M&A and investor relations.

SALAM GABRAN
CHIEF SCIENTIST
10+ years of professional experience in research and development in the fields of microfabrication, flexible electronics, wearable devices, neuro-modulation, medical implants and embedded systems. PhD University of Waterloo.

PETER MANKOWSKI
CTO
Passionate IoT and AI Technologist, with a strong track record of inventions, patents and publications.
 

MARK VALENTINE
SVP BUSINESS DEVELOPMENT & IP PORTFOLIO
Medical and technology company executive with over 20 years of experience in sales and marketing of emerging growth companies.

JAY KASBERGER
DIRECTOR OF PLATFORM DEVELOPMENT
Developer of bioinformatics analytical pipelines, with over 2 decades of developing medical device software and lab informatics. With a BS in Biology and a Ph.D. program research fellow in Computer Science/Cognitive Science. 

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.


Request Access

N

No updates yet.




%

No backers yet.




Quick Signup TBD

You must have an account to do this!


the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.